Catalyst Wire Dossier Catalyst Wire Dossier

XIENCE V Everolimus Eluting Coronary Stent System

Everolimus-eluting coronary stent · Abbott Vascular
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for XIENCE V Everolimus Eluting Coronary Stent System, covering 2008-12-15 to 2013-10-11. Get the full timeline:

Most recent: Clinical Trial Update: XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort)

See pricing